Literature DB >> 34116477

ADP-ribosylation of DNA and RNA.

Joséphine Groslambert1, Evgeniia Prokhorova1, Ivan Ahel2.   

Abstract

ADP-ribosylation is a chemical modification of macromolecules found across all domains of life and known to regulate a variety of cellular processes. Notably, it has a well-established role in the DNA damage response. While it was historically known as a post-translational modification of proteins, recent studies have shown that nucleic acids can also serve as substrates of reversible ADP-ribosylation. More precisely, ADP-ribosylation of DNA bases, phosphorylated DNA ends and phosphorylated RNA ends have been reported. We will discuss these three types of modification in details. In a variety of bacterial species, including Mycobacterium tuberculosis, ADP-ribosylation of thymidine has emerged as the mode of action of a toxin-antitoxin system named DarTG, with the resultant products perceived as DNA damage by the cell. On the other hand, mammalian DNA damage sensors PARP1, PARP2 and PARP3 were shown to ADP-ribosylate phosphorylated ends of double-stranded DNA in vitro. Additionally, TRPT1 and several PARP enzymes, including PARP10, can add ADP-ribose to the 5'-phosphorylated end of single-stranded RNA in vitro, representing a novel RNA capping mechanism. Together, these discoveries have led to the emergence of a new and exciting research area, namely DNA and RNA ADP-ribosylation, that is likely to have far-reaching implications for the fields of DNA repair, replication and epigenetics.
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ADP-ribosylation; DNA damage response; DNA modification; PARP; RNA modification

Year:  2021        PMID: 34116477     DOI: 10.1016/j.dnarep.2021.103144

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  11 in total

1.  PARP1 and XRCC1 exhibit a reciprocal relationship in genotoxic stress response.

Authors:  Julia M Reber; Jovana Božić-Petković; Michelle Lippmann; Marvin Mazzardo; Asisa Dilger; Rebecca Warmers; Alexander Bürkle; Aswin Mangerich
Journal:  Cell Biol Toxicol       Date:  2022-07-01       Impact factor: 6.691

Review 2.  Research Progress on Mono-ADP-Ribosyltransferases in Human Cell Biology.

Authors:  Yujie Gan; Huanhuan Sha; Renrui Zou; Miao Xu; Yuan Zhang; Jifeng Feng; Jianzhong Wu
Journal:  Front Cell Dev Biol       Date:  2022-05-16

3.  Bioengineered Silkworm for Producing Cocoons with High Fibroin Content for Regenerated Fibroin Biomaterial-Based Applications.

Authors:  Mana Yamano; Ryoko Hirose; Ping Ying Lye; Keiko Takaki; Rina Maruta; Mervyn Wing On Liew; Shinichi Sakurai; Hajime Mori; Eiji Kotani
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

Review 4.  The expanding universe of PARP1-mediated molecular and therapeutic mechanisms.

Authors:  Dan Huang; W Lee Kraus
Journal:  Mol Cell       Date:  2022-03-09       Impact factor: 19.328

Review 5.  NAD+-consuming enzymes in immune defense against viral infection.

Authors:  Jialin Shang; Michael R Smith; Ananya Anmangandla; Hening Lin
Journal:  Biochem J       Date:  2021-12-10       Impact factor: 3.857

6.  Beyond protein modification: the rise of non-canonical ADP-ribosylation.

Authors:  Marion Schuller; Ivan Ahel
Journal:  Biochem J       Date:  2022-02-17       Impact factor: 3.857

Review 7.  Are PARPs promiscuous?

Authors:  Karla L H Feijs; Roko Žaja
Journal:  Biosci Rep       Date:  2022-05-27       Impact factor: 3.840

8.  ADP-ribosylation of RNA in mammalian cells is mediated by TRPT1 and multiple PARPs.

Authors:  Lisa Weixler; Karla L H Feijs; Roko Zaja
Journal:  Nucleic Acids Res       Date:  2022-08-26       Impact factor: 19.160

Review 9.  Functional roles of ADP-ribosylation writers, readers and erasers.

Authors:  Ping Li; Yushuang Lei; Jia Qi; Wanqin Liu; Kai Yao
Journal:  Front Cell Dev Biol       Date:  2022-08-11

10.  TARG1 protects against toxic DNA ADP-ribosylation.

Authors:  Callum Tromans-Coia; Andrea Sanchi; Giuliana K Moeller; Gyula Timinszky; Massimo Lopes; Ivan Ahel
Journal:  Nucleic Acids Res       Date:  2021-10-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.